Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: A Danish nationwide cohort study

Annals of Internal Medicine

Volumn 156, Issue 12, 2012, Pages 841-847

  Jepsen, Peter ^a   Ott, Peter ^a   Andersen, Per Kragh ^b   Sørensen, Henrik Toft ^a   Vilstrup, Hendrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

EID: 84862743466     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-156-12-201206190-00004     Document Type: Article

References (35)

1. Sørensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer L, Linet M, et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology. 1998;28:921-5. [PMID: 9755226]
2. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53: 1020-2. [PMID: 21374666]
3. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-36. [PMID: 16250051]
4. Yang JD, Harmsen WS, Slettedahl SW, Chaiteerakij R, Enders FT, Therneau TM, et al. Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol. 2011;9:617-23. e1. [PMID: 21459158]
5. Sherman M. Hepatocellular carcinoma: screening and staging. Clin Liver Dis. 2011;15:323-34, vii-x. [PMID: 21689616]
6. Braillon A. Screening for hepatocellular carcinoma: from lack of evidence to common sense [Letter]. Hepatology. 2010;52:1863-4. [PMID: 20658463]
7. Dans LF, Silvestre MA, Dans AL. Trade-off between benefit and harm is crucial in health screening recommendations. Part I: general principles. J Clin Epidemiol. 2011;64:231-9. [PMID: 21194890]
8. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118-27. [PMID: 21992124]
9. Kuper H, Ye W, Broomé U, Romelsjö A, Mucci LA, Ekbom A, et al. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology. 2001;34:714-8. [PMID: 11584367]
10. Fleming K, Card TR, Aithal GP, West J. Incidence of hepatocellular carcinoma among people with alcoholic or cryptogenic cirrhosis in the general population of the UK [Abstract]. Hepatology. 2010;52:913A.
11. Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigenand anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Alcohol Clin Exp Res. 2003;27:47S-51S. [PMID:12960507]
12. Toshikuni N, Izumi A, Nishino K, Inada N, Sakanoue R, Yamato R, et al. Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis. J Gastroenterol Hepatol. 2009;24:1276-83. [PMID: 19486451]
13. Torisu Y, Ikeda K, Kobayashi M, Hosaka T, Sezaki H, Akuta N, et al. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report. Hepatol Res. 2007;37:517-23. [PMID: 17539994]
14. Solà R, Alvarez MA, Ballesté B, Montoliu S, Rivera M, Miquel M, et al. Probability of liver cancer and survival in HCV-related or alcoholicdecompensated cirrhosis. A study of 377 patients. Liver Int. 2006;26:62-72. [PMID: 16420511]
15. N'Kontchou G, Paries J, Htar MT, Ganne-Carrie N, Costentin L, Grando-Lemaire V, et al. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. Clin Gastroenterol Hepatol. 2006;4:1062-8. [PMID:16844421]
16. Jepsen P, Vilstrup H, Sørensen HT. Alcoholic cirrhosis in Denmark-population-based incidence, prevalence, and hospitalization rates between 1988 and 2005: a descriptive cohort study. BMC Gastroenterol. 2008;8:3. [PMID:18261240]
17. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-8. [PMID: 10421985]
18. Omland LH, Krarup H, Jepsen P, Georgsen J, Harritshøj LH, Riisom K, et al; DANVIR Cohort Study. Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study. J Hepatol. 2010;53:36-42. [PMID: 20400197]
19. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull. 1997;44:535-9. [PMID: 9408738]
20. Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer. 2004;91: 1229-35. [PMID: 15305188]
21. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
22. Yang JD, Kim WR. Surveillance for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10:16-21. [PMID: 21699816]
23. European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2012;56:908-43. [PMID: 22424438]
24. Poole C. Beyond the confidence interval. Am J Public Health. 1987;77: 195-9. [PMID: 3799860]
25. Olsen J, Basso O, Sørensen HT. What is a population-based registry? [Letter]. Scand J Public Health. 1999;27:78. [PMID: 10847676]
26. del Olmo JA, Serra MA, Rodri{dotless}́guez F, Escudero A, Gilabert S, Rodrigo JM. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis. J Cancer Res Clin Oncol. 1998;124:560-4. [PMID: 9829860]
27. Alvarez MA, Cirera I, Solà R, Bargalló A, Morillas RM, Planas R. Longterm clinical course of decompensated alcoholic cirrhosis: a prospective study of165 patients. J Clin Gastroenterol. 2011;45:906-11. [PMID: 21814145]
28. Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2007;5:938-45, 945. e1-4. [PMID: 17509946]
29. Vestberg K, Thulstrup AM, Sørensen HT, Ottesen P, Sabroe S, Vilstrup H. Data quality of administratively collected hospital discharge data for liver cirrhosis epidemiology. J Med Syst. 1997;21:11-20. [PMID: 9172066]
30. Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M, et al. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst. 2011;103:1686-95. [PMID:22021666]
31. Altman DG, Bland JM. Diagnostic tests 2: Predictive values. BMJ. 1994;309:102. [PMID: 8038641]
32. Sangiovanni A, Colombo M. Surveillance for hepatocellular carcinoma: a standard of care, not a clinical option [Editorial]. Hepatology. 2011;54:1898-900. [PMID: 21932397]
33. Poustchi H, Farrell GC, Strasser SI, Lee AU, McCaughan GW, George J. Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed? Hepatology. 2011;54:1998-2004. [PMID: 21800340]
34. Jepsen P, Ott P, Andersen PK, Sørensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2010;51:1675-82. [PMID: 20186844]
35. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-54.